Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2025-12-24 @ 11:25 PM
NCT ID:
NCT01073956
Eligibility Criteria:
Inclusion Criteria:
* Men and women over 18 years of age
* Shoulder pain secondary to subacromial impingement syndrome
* Pain at rest and/or with free movement and/or with movement against resistance with a score on the visual analogue scale of 3 or higher.
* Documented X-ray (XR), ultrasound (US) and/or magnetic resonance imaging (MRI) evidence of cuff injury involving oedema, tendonitis, fibrosis or torn tendon.
* Potentially available for the next six months.
Exclusion Criteria:
* Documented US and/or MRI evidence of complete tearing of the cuff and clinical inability to lift the arm (drop arm sign)
* Radiological findings of tumour lesions, avascular necrosis, glenoid development defects, acromial bone, severe degenerative signs affecting inter-articular space and fractures
* Limited range of passive movement with capsular pattern
* Recent history of trauma (contusion, falls or sudden jarring)
* Ischaemic cardiopathy in subacute phase
* History of more than five infiltrations and/or shoulder surgery
* History of rehabilitation treatment for the same reason in the last 12 months
* Cognitive deficit, psychiatric alterations or behavioural disorders that might compromise the patient's collaboration
* Unsuitable for electrotherapy: pregnancy, epilepsy, pacemaker, osteosynthesis, undergoing treatment with Sintrom
* Patients in litigation or in the process of making work-related claims
* Failure to understand Spanish
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01073956
Study Brief:
Protocol Section:
NCT01073956